C4B and metabolic dysfunction-associated steatotic liver disease: We found that patients with NAFLD did not differ in terms of age, sex, height, blood pressure values and the assessed markers of carbohydrate metabolism (FPG, PPG, HbA1c) or kidney function (creatinine, urea, eGFR), T-CH, LDL-CH, HDL-CH, total bilirubin, and uric acid concentrations from the −NAFLD group.